People might start to exhibit symptoms of SARS-CoV-2 in five days finds new study

The quarantine period of 14 days being followed worldwide is good enough to observe a person suspected of being sick.

tech2 News Staff March 10, 2020 14:48:50 IST
People might start to exhibit symptoms of SARS-CoV-2 in five days finds new study

A new study has found that the incubation period for SARS-CoV-2 is around five days. To recap, SARS-CoV-2 is the coronavirus that causes the disease COVID-19. Coronaviruses are a large family of viruses that may cause illness in animals or humans.

The incubation period is the time from exposure to the virus until the first symptoms develop in a person, and is characteristic for each disease agent.

People might start to exhibit symptoms of SARSCoV2 in five days finds new study

This scanning electron microscope image shows SARS-CoV-2 (orange) — also known as 2019-nCoV, the virus that causes COVID-19 — isolated from a patient in the U.S., emerging from the surface of cells (green) cultured in the lab. Image credit: AP

For this specific SARS-CoV-2, the median incubation period is 5.1 days, and the study suggests that about 97.5 percent of people who develop symptoms of this virus will start to exhibit symptoms within 11.5 days of exposure.

Hence the quarantine period of 14 days that is being followed worldwide is a good enough time period to observe a person who is suspected of being exposed to the virus.

However, the researchers said that for every 10,000 people who are quarantined for 14 days, an estimated 101 people would develop symptoms after being released from quarantine.

"Based on our analysis of publicly available data, the current recommendation of 14 days for active monitoring or quarantine is reasonable, although with that period some cases would be missed over the long-term," said Justin Lessler, an associate professor in the Bloomberg School's Department of Epidemiology in a statement.

The researches looked at 181 cases of people from China and other countries that were detected prior to 24 February and those that were reported in the media and included likely dates of exposure and symptom onset. They all have either a history of travel to Wuhan or Hubei in China.

The findings were published in the journal Annals of Internal Medicine.

Updated Date:

also read

Sunpharma launches Favipiravir tablet Fluguard to treat mild to moderate COVID-19 infections at Rs 35 per pill
science

Sunpharma launches Favipiravir tablet Fluguard to treat mild to moderate COVID-19 infections at Rs 35 per pill

Favipiravir is an antiviral drug that was originally made to treat influenza in Japan under the brand name Avigan.

Russia's COVID-19 vaccine to enter production, deliver first batch of doses in two weeks
science

Russia's COVID-19 vaccine to enter production, deliver first batch of doses in two weeks

The vaccine is given in two doses and will help people develop immunity to the virus for at least two years.

Mildly ill COVID-19 patients can be discharged in nine or more days after symptom onset: Hong Kong study
India

Mildly ill COVID-19 patients can be discharged in nine or more days after symptom onset: Hong Kong study

According to the research, patients with mild or moderate illness might be less contagious eight days after symptom onset.